Avanos Medical (AVNS) Change in Accured Expenses (2013 - 2026)

Avanos Medical has disclosed Change in Accured Expenses across 14 years of filings, most recently posting -$33.7 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 127.7% year-over-year to -$33.7 million; the TTM figure through Mar 2026 stood at -$31.8 million (down 2371.43% YoY), while the FY2025 annual figure was -$12.9 million, down 13.16% from the prior year.
• Change in Accured Expenses came in at -$33.7 million for Q1 2026 at Avanos Medical, down from $9.5 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $17.4 million in Q3 2023 to a low of -$33.7 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is -$5.5 million, with a median of -$7.2 million recorded in 2025.
• Year-over-year, Change in Accured Expenses tumbled 3300.0% in 2023 and jumped 276.04% in 2024.
• Over 5 years, Change in Accured Expenses stood at $11.4 million in 2022, then plunged by 170.18% to -$8.0 million in 2023, then climbed by 3.75% to -$7.7 million in 2024, then soared by 223.38% to $9.5 million in 2025, then plunged by 454.74% to -$33.7 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$33.7 million in Q1 2026, $9.5 million in Q4 2025, and -$400000.0 in Q3 2025.